Chemoinformaics analysis of 9,10-Dihydrophenanthrene
| Molecular Weight | 180.25 | nRot | 0 |
| Heavy Atom Molecular Weight | 168.154 | nRig | 1 |
| Exact Molecular Weight | 180.094 | nRing | 3 |
| Solubility: LogS | -3.753 | nHRing | 0 |
| Solubility: LogP | 4.254 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 2 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 12 |
| nHA | 0 | APOL | 31.3815 |
| nHD | 0 | BPOL | 12.0385 |
| QED | 0.429 |
| Synth | 1.674 |
| Natural Product Likeliness | 0.574 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.032 |
| Pgp-sub | 0.003 |
| HIA | 0.002 |
| CACO-2 | -4.5 |
| MDCK | 0.0000264 |
| BBB | 0.973 |
| PPB | 0.886242 |
| VDSS | 1.025 |
| FU | 0.171828 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.344 |
| CYP2c19-inh | 0.698 |
| CYP2c19-sub | 0.217 |
| CYP2c9-inh | 0.422 |
| CYP2c9-sub | 0.675 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.094 |
| CYP3a4-inh | 0.117 |
| CYP3a4-sub | 0.143 |
| CL | 4.084 |
| T12 | 0.5 |
| hERG | 0.097 |
| Ames | 0.007 |
| ROA | 0.031 |
| SkinSen | 0.926 |
| Carcinogencity | 0.139 |
| EI | 0.989 |
| Respiratory | 0.349 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.600723 |